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Abstract  
Background: Bilirubin is stated to be a negative interferent in some biuret assays and thus could  
contribute to pseudohypoproteinemia in icteric samples.  
Objective: The purpose of the study was to evaluate the magnitude of and reason for a falsely  
low total protein concentration in icteric serum when the protein concentration is measured with  
a bichromatic spectrophotometric biuret assay.  
Methods: Commercially available bilirubin was dissolved in 0.1 M NaOH and then mixed with  
sera from 2 dogs to achieve various bilirubin concentrations of up to 40 mg/dL (first set of  
samples) and 35 mg/dL (second set of samples, for confirmation of first set of results and to  
explore the interference). Biuret total protein and bilirubin concentrations were determined with  
a chemistry analyzer (Cobas 6000 Cobaswith  c501 module). Line graphs were drawn to  
illustrate the effects of increasing bilirubin concentrations on the total protein concentrations.  
Specific spectrophotometric absorbance readings were examined to identify the reason for the  
negative interference.  
Results: High bilirubin concentrations created a negative interference in the Cobas c501 biuret  
assay. The detectable interference occurred with a spiked bilirubin concentration of 10.7 mg/dL  
in one set of samples and 20.8 mg/dL in a second set. The interference was due to a greater  
secondary absorbance reading at the second measuring point in the samples spiked with  
bilirubin, which possibly had converted to biliverdin.  
Conclusion: Marked hyperbilirubinemia is associated with a falsely low serum total protein  
concentrations when measured with a bichromatic spectrophotometric biuret assay. This can 
result in pseudohypoproteinemia and pseudohypoglobulinemia in icteric serum.  
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Introduction  
 There are 2 common analytical methods of determining plasma or serum total protein  
concentrations:  biuret spectrophotometric assays and refractometry.  A recent case report  
described a pseudohypoproteinemia in markedly icteric serum when the serum was assayed with  
a biuret total protein assay.1 However, the bilirubin concentration at which the interference  
becomes detectable was not established. In the case report, the refractometric total protein  
concentration did not appear to be adversely affected by the hyperbilirubinemia. A recent report  
established that serum bilirubin concentrations as high as 41 mg/dL do not affect the estimation  
of total protein concentrations by refractometry.2  
The biuret method is the most common spectrophotometric method of measuring serum  
total protein concentration. The biuret reaction depends on the number of peptide bonds in the  
sample; thus, the protein concentration in the sample. In the reaction, proteins form complexes 
with copper in alkaline solutions and create a blue-purple product; the amount of product is  
measured with spectrophotometry. The method is named biuret method because a similar copper  
reaction occurs with the organic compound biuret, a condensation product of 2 urea molecules.  
Some package inserts state that bilirubin can interfere with the biuret assay, but the magnitude of  
interference or reason for the interference is not typically stated.  
Even though the method’s chemical principle is constant, there are assay variations used  
by manufacturers of the biuret reagents. The package inserts for 2 biuret assays (Roche Cobas’  
c501 and Roche Hitachi module P, Roche Diagnostics, Indianapolis, IN, USA) state that an  
icteric index up to 20 (approximately 20 mg/dL or 342 mol/L) and 21 (approximately 21 mg/dL  
or 359 mol/L), respectively, have no significant effects (ie, protein recovery is expected to be  
within 10 % of the initial value). In another biuret method (Roche Cobas Integra 400/800), the  
package insert states no significant bilirubin interference (ie, error < 10 %). For another  
company’s biuret assay (Beckman-Coulter, Brea, CA, USA), the package insert states that a  
bilirubin concentration of up to 40 mg/dL (684 mol/L) has no significant effect (ie, error < 10  
%) on the results. For another biuret assay (Vitros, Ortho Clinical Diagnostics, Rochester, NY,  
USA), the package insert states a maximum observed bias of 3 % with bilirubin concentrations 
of 15 mg/dL (256 mol/L), but states possible test-to-test variation. A recent study indicated an  
icteric index of 14 causes a decreased total protein concentration when measured with the Cobas  
6000 assay, but the magnitude of interference was not stated.3 Occasionally, it is also stated that  
icterus causes a positive interference with the biuret assay and results in falsely increased protein  
measurements.4  
This study evaluated the effect of adding increasing amounts of bilirubin on a biuret  
serum total protein assay.   
  
Materials and methods  
  
Blood collection   
For each set of samples, venous blood was collected from a healthy, fasted Greyhound  
dog with syringes and then transferred to evacuated tubes. After approximately 30 min, tubes  
were centrifuged and nonlipemic and nonhemolyzed sera were harvested.   
  
Bilirubin stock solution and preparing icteric sera  
 A bilirubin stock solution of 400 mg/dL was prepared by dissolving 40 mg of bilirubin  
powder (Sigma-Aldrich, St. Louis, MO) in 10 mL of 0.1 M sodium hydroxide (NaOH).5,6  Serial  
dilutions of the bilirubin stock solution with 0.1 M NaOH were mixed with constant proportions  
of sera (1 part bilirubin solution + 9 parts serum) to create bilirubin concentrations between 1 and  
40 mg/dL (17 and 684 mol/L) in the first set of spiked sera, and between 4 and 35 mg/dL (68  
and 598 mol/L) in the second set of spiked sera. The first set of spiked sera was assayed to  
document the interference; the second set was assayed to confirm findings of the first set, and to  
explore the reason for the interference. Control sera were prepared by mixing with 0.1 M NaOH  
solution in comparable proportions. Based on a previous study using the same preparation  
methods, nearly all bilirubin in the spiked sera was unconjugated.2  
  
Assays for serum total protein, total bilirubin, and direct bilirubin concentrations  
Clinical chemistry assays were completed on the day of blood collection using an  
automated chemistry analyzer (Cobas 6000 with Cobas c501 module, Roche Diagnostics,  
Indianapolis, IN, USA) and the manufacturer’s reagents. The analyzer used a reaction  
monitoring system in which absorbance readings were recorded while the reaction cuvette,  
located on a rotating reaction disc, passed across the optical path of the instrument’s photometer.  
Each analytical assay had specific timed readings for the calculation of an analyte’s  
concentration.   
The total bilirubin assay was a modified Malloy-Evelyn method.7 Samples with bilirubin  
concentrations > 35 mg/dL were automatically diluted. Indices for lipemia, hemolysis and icterus  
were calculated by the chemistry analyzer by using absorbance differences at 3 bichromatic 
wavelength pairs (700/660 for lipemia, 600/570 for hemolysis, and 505/480 for icterus), and the  
icterus index was reported as a number that approximates the total bilirubin concentration (in  
mg/dL).8  
The analyzer’s biuret total protein assay was a 2-point-end, bichromatic assay (Figure 1),9  
it will be referred to as the bichromatic biuret assay from this point forward; the formulae used to  
calculate the total protein concentration in a sample are provided (Figure 2).9 During the  
previous 5 months and including the weeks of this study, the coefficient of variation (CV) for the  
bichromatic biuret assay were 1.5 % for commercial level-1 human control serum (mean  
concentration of 6.0 g/dL, standard deviation 0.1 g/dL) and 1.5 % for commercial level-2 human  
control serum (mean concentration of 4.4 g/dL, standard deviation of 0.1 g/dL). Based on the  
assay’s analytical precision, any change to biuret total protein concentration in the spiked  
samples that was > 0.2 g/dL was considered a true change/interference and not a random analytic  
error.  
A refractometer (Leica TS Meter Refractometer Model 10400B) with a total solids  
percent scale (g/100g) was used to determine refractometric total protein concentrations. The  
total solids percentage of a sample was converted to a total protein concentration (g/dL) using  
Wolf’s conversion table.910 This method of obtaining a refractometric total protein concentration  
was selected because it provided the best agreement with the bichromatic biuret assay among 3 
available refractometers.2 The refractometer was calibrated with deionized water to 1.000 on the  
urine specific gravity scale prior to sample analysis. To monitor analytical precision the day of  
analyzing the first set of sera, the prespiked serum was analyzed 8 times by refractometry and the  
bichromatic biuret assay.  
The first set of spiked sera was analyzed by refractometry and the bichromatic biuret  
assay in duplicates, and the mean concentration of each sample was recorded for comparisons.  
The second set of prespiked and spiked sera was assayed 5 times, and the mean concentration of  
each sample was recorded for comparisons. In both sets of samples, the biuret total protein  
concentrations were evaluated to detect negative interference. Actual absorbance data of the  
second set of spiked sera were evaluated to determine the reason for the negative interference.  
  
Results   
The mean total protein concentration in the first prespiked serum by both methods  
(refractometry and biuret reaction) was 5.8 g/dL (CV 0.9 % and 1.4 %, respectively).   
In the first set of spiked sera, lower bichromatic biuret total protein concentrations (> 0.2  
g/dL decrease compared to protein concentration in the NaOH sample) were first seen at a  
bilirubin concentration of 10.7 mg/dL, corresponding to an icteric index of 16 (Figure 3, sample  
S7).  Whereas, refractometric total protein concentrations ranged from 5.0 - 5.2 g/dL in the same  
spiked sera (Figure 3).   
In the second set of spiked sera, lower bichromatic biuret total protein concentrations  
occurred at a bilirubin concentration of 20.8 mg/dL (356 mol/L) (corresponding to an icteric  
index of 29) and at greater bilirubin concentrations (Figure 4).  
The analysis of the actual absorbance data (Table 1) provided additional information for  
the observed bilirubin interference:  
1. At the first measuring point (mp1), the measured primary absorbance values at 546 nm  
increased proportional to increasing bilirubin concentrations because bilirubin absorbs the  
546 nm light. Minor fluctuations in the secondary absorbance values at 700 nm reflect  
analytical variation, as the 700 nm light is not absorbed by bilirubin.  
2. At the second measuring point (mp2) and thus at the end of the biuret reaction producing a  
blue-purple product, the measured primary absorbance values at 546 nm were variable but  
greatest in the spiked sera with the highest bilirubin concentrations, reflecting that both 
bilirubin and the product of the biuret reaction were contributing to the primary absorbance  
values. The secondary absorbance values at 700 nm increase mildly for samples with 
bilirubin concentrations up to 9.9 mg/dL (169 mol/L), then more abruptly at 20.8 mg/dL,  
31.7 mg/dL, and 36.3 mg/dL (356 mol/L, 542 mol/L, and 621 mol/L).   
3. Amp1 values are the mathematical differences between the measured absorbance values at  
546 nm and 700 nm at the first measuring point (mp1). The difference increased as the  
bilirubin concentrations increased reflecting the absorbance of the 546 nm light by bilirubin.  
The Amp1 value is used in the calculation of the protein concentration (Figure 2).   .  
4. Amp2 values are the mathematical differences between the measured absorbance values at  
546 nm and 700 nm at the second measuring point (mp2). Amp2 values fluctuated with  
bilirubin concentration of up to 9.9 mg/dL (169 mol/L), then declined at greater bilirubin  
concentrations. The decreasing Amp2 values correspond with the abrupt increases in the  
secondary absorbance values of at the end of the bichromatic biuret reaction reflecting the  
presence of an interfering substance.  The Amp2 value is used in the calculation of the protein  
concentration (Figure 2). Examples of the calculations are shown in Figure 5.    
5. Ax values are calculated using the absorbance values from the first and second measuring  
points (Amp1 and Amp2, respectively) (Figure 2). There are minor changes in the Ax values  
with bilirubin concentration of up to 9.9 mg/dL (169 mol/L), then decreased abruptly at  
greater bilirubin concentrations reflecting the appearance of the interfering substance.     
6. The lowering of the total protein concentration to 5.0 g/dL from the prespike concentration  
(5.5 g/dL) reflects the dilution of the protein concentration when the NaOH solution was  
added. When spiked with the bilirubin solutions, the measured protein concentration varied  
minimally up to the bilirubin concentration of  9.9 mg/dL (169 mol/L), and then decreased  
abruptly at greater bilirubin concentrations reflecting the appearance of the interfering  
substance.      
  
Discussion  
Increasing serum bilirubin concentrations in both sets of spiked sera resulted in a  
negative interference of the measurement of the total protein concentration by the bichromatic  
biuret method while the refractometric total protein concentrations remained the same in the first  
set of spiked samples.    
The maximum spectral absorption of bilirubin in serum is near 455 nm,1011 therefore, the  
interfering agent found in the secondary-wavelength (700 nm) absorbance was likely not  
bilirubin. However, bilirubin can be degraded to biliverdin in an alkaline environment.1112  
Because the biuret reaction occurred in an alkaline solution, we hypothesize that some of the  
bilirubin converted to biliverdin, which has maximum spectral absorbance near 700 nm,12,1313,14  
the secondary wavelength of the evaluated biuret assay. Assays to measure biliverdin  
concentrations were not attempted and thus this hypothesis was not tested or confirmed.  
Nevertheless it can be assumed that the degree of interference due to biliverdin or another  
compound derived from bilirubin will be roughly proportional to the initial amount of bilirubin  
present in the reaction cuvette. Until the identity and property of such compounds are clarified, it  
will be difficult to predict to what degree hyperbilirubinemia will interfere with bichromatic  
biuret assay.  
The presence of a decreased total protein concentration in the presence of marked  
hyperbilirubinemia could lead to erroneous conclusions if the pseudohypoproteinemia is not  
recognized.. This study documents that marked hyperbilirubinemia can be associated with a false  
decrease in the serum total protein concentration measured by a bichromatic biuret assay. The  
interferent is not bilirubin but is related to the presence of bilirubin in the serum. The negative  
interference was found in one bichromatic, 2-point-end assay; it is not known if a similar  
interference will be found with other biuret assays.   
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Figure Legends  
  
Figure 1:  The bichromatic biuret assay (Cobas 6000 with Cobas c501 module, Roche  
Diagnostics, Indianapolis, IN, USA) is a 2-point-end spectrophotometric assay. After addition of  
water (blank) to the reaction cuvette, 3 absorbance readings are taken (C1, C2, & C3). After the  
addition of the sample (S) and first reagent (R1) that contains NaOH and a buffer, the first  
measuring point (mp1) at the 10th absorbance reading (Amp1) is obtained. After addition of the  
second reagent (R2) that contains NaOH, a buffer, potassium iodide, and copper sulfate and a  
specified time interval, the second measuring point (mp2) at the 34th absorbance reading (Amp2)  
is obtained. The second measuring point designates the end of the assay. If protein is present in  
the sample, then Amp2 is greater than Amp1. It is a bichromatic assay because 2 absorbance  
readings are recorded at each measuring point: 1) primary-wavelength absorbance at 546 nm  
represents the total absorbance of the cuvette; 2) secondary-wavelength absorbance at 700 nm  
represents any absorbance due to an interfering substance such as lipids. After compensating for  
dilution in the reaction cuvette at mp2, the absorbance at mp1 (Amp1) is subtracted from  
absorbance at mp2 (Amp2) to determine the change in absorbance due to the product of the biuret  
reaction. (Figure modeled after figure within Roche Diagnostics literature for its Cobas c501  
instrument.9)    
  
Figure 2: Formulas used to calculate total protein concentration in the bichromatic biuret assay  
(Cobas 6000 with Cobas c501 module, Roche Diagnostics, Indianapolis, IN, USA).  (Figure  
modeled after similar equations within Roche Diagnostics literature for its Cobas c501  
instrument.9)  
  
Figure 3: Means of duplicate measurements of refractometric () and bichromatic biuret (– – 
) total protein concentrations in sera spiked with only NaOH solution or with increasing amounts  
of bilirubin. The measured bilirubin concentrations (- -  - -) were determined by a modified  
Malloy-Evelyn method (Cobas 6000 withCobas c501 module, Roche Diagnostics,  
Indianapolis, IN, USA). The biuret total protein concentrations were nearly constant up to a total  
bilirubin concentration of 6.8 mg/dL (116 mol/L) (sample S6), then decreased in a near linear  
progression to a total protein concentration of 4.1 g/dL when the bilirubin concentration was 41.5  
mg/dL (710 mol/L). The minor changes in refractometric total protein concentrations were  
considered to be within the analytical variation and thus high bilirubin concentrations did not  
interfere with the refractometric estimations of the total protein concentrations.   
  
Figure 4: Means of quintuplicate absorbance values (Ax) () that were used to calculate biuret  
total protein concentrations (numerical value of the protein concentration {g/dL} below each  
plotted point) and mean of duplicate measurements of bilirubin concentrations (- -  - -)  
(numerical value of icteric index below each plotted point) in sera spiked with only NaOH  
solution or with increasing amounts of bilirubin. The measured bilirubin concentrations were  
determined by a modified Malloy-Evelyn method (Cobas 6000 with Cobas c501 module,  
Roche Diagnostics, Indianapolis, IN, USA). The biuret total protein concentrations were nearly  
constant up to a total bilirubin concentration of 9.9 mg/dL (169 mol/L) (sample S7), then  
decreased in a near linear progression to a total protein concentration of 4.0 g/dL when the  
bilirubin concentration was 36.3 mg/dL (621 mol/L). The second absorbance values (Amp2)  
() and first absorbance values (Amp1) ( ) are plotted for each spiked sample; those values  
are used to calculate the Ax (Figure 2). When the samples’ bilirubin concentrations were 20.8  
mg/dL (356 mol/L, icteric index = 29) (sample S8) and greater, there were obvious decreases in  
Amp2 and minor increases in (Amp1) which results in a lower calculated Ax. These absorbance  
changes resulted in falsely low total protein concentrations.  
  
Figure 5: Calculation of total protein concentrations in “NaOH only” sample and “S8” serum  
samples in the second set of sera (see Table 1 for sources of absorbance values)   
Table 1: Total bilirubin concentrations and absorbance values in the bichromatic biuret serum total protein assay of the chemical 
analyzer (Cobas 6000 with Cobas c501 module) with bilirubin spiked normal canine sera  
Sample [Total 
bilirubin] 
(mg/dL)  
 Absorbance data 
   mp1  mp2  Amp1  Amp2   
Ax 
Biuret  
[total protein] 
(g/dL) 
 1A||   2A**  1A  2A  1A – 2A  1A – 2A  
Prespike 0.1  0.0000 -0.0006  0.2342 0.1241  0.0006  0.1101  0.1097 5.5 
Controls 
(NaOH 
only) 
0.1  0.0005 -0.0002  0.2168 0.1236  0.0007  0.0932  0.0927 5.0 
S1 4.0  0.0011 -0.0004  0.2140 0.1282  0.0015  0.0858  0.0847 4.9 
S2 4.9  0.0016 -0.0003  0.2161 0.1293  0.0019  0.0868  0.0854 4.9 
S3 6.0  0.0026 0.0004  0.2195 0.1296  0.0022  0.0899  0.0883 4.9 
S4 7.2  0.0023 -0.0004  0.2183 0.1319  0.0027  0.0864  0.0844 4.7 
S5 8.4  0.0030 -0.0002  0.2218 0.1319  0.0032  0.0899  0.0875 4.8 
S6 9.4  0.0030 -0.0003  0.2175 0.1334  0.0033  0.0841  0.0817 4.7 
S7 9.9  0.0033 -0.0001  0.2208 0.1331  0.0034  0.0877  0.0852 4.8 
S8 20.8  0.0071 0.0004  0.2208 0.1439  0.0067  0.0769  0.0719 4.4 
S9 31.7  0.0099 0.0007  0.2223 0.1522  0.0092  0.0701  0.0633 4.2 
S10 36.3  0.0120 0.0006  0.2262 0.1586  0.0114  0.0676  0.0591   4.0 
* mp1: first measuring point of primary and secondary absorbance values, reaction cuvette contains water, sample, and the first reagent. 
† mp2: second measuring point of primary and secondary absorbance values, the reaction cuvette contains water, sample, first reagent, 
and second reagent; biuret reaction completed 
‡ Amp1 = difference of primary and secondary absorbance values at mp1. 
§ Amp2 = difference of primary and secondary absorbance values at mp2. 
¶ Ax = the calculated absorbance value (see Figure 2) that is used to calculate a sample’s total protein concentration  
||1A is the primary absorbance for the biuret assay at 546 nm which represents total absorbance by the reaction cuvette. 
**2A is the secondary absorbance for the biuret assay at 700 nm which represents absorbance due to interfering substances. 
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